ROYAL BANK OF CANADA - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 120 filers reported holding ALDEYRA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$39,000
+62.5%
5,841
+101.3%
0.00%
Q2 2023$24,000
+500.0%
2,901
+673.6%
0.00%
Q1 2023$4,000
-73.3%
375
-82.2%
0.00%
Q4 2022$15,000
+25.0%
2,112
-6.2%
0.00%
Q3 2022$12,000
+200.0%
2,252
+133.9%
0.00%
Q2 2022$4,000
-69.2%
963
-68.0%
0.00%
Q1 2022$13,000
-69.0%
3,008
-71.5%
0.00%
Q4 2021$42,000
+5.0%
10,557
+131.5%
0.00%
Q3 2021$40,000
-9.1%
4,560
+19.4%
0.00%
Q2 2021$44,000
+29.4%
3,818
+34.8%
0.00%
Q1 2021$34,000
+100.0%
2,832
+11.5%
0.00%
Q4 2020$17,000
-10.5%
2,5400.0%0.00%
Q3 2020$19,000
+11.8%
2,540
-39.8%
0.00%
Q2 2020$17,000
+112.5%
4,222
+27.5%
0.00%
Q1 2020$8,000
-66.7%
3,311
-19.3%
0.00%
Q4 2019$24,0004,102
+4310.8%
0.00%
Q3 2019$093
+132.5%
0.00%
Q2 2019$0400.0%0.00%
Q1 2019$0400.0%0.00%
Q4 2018$0
-100.0%
40
-86.8%
0.00%
Q3 2018$5,000
+400.0%
302
+36.0%
0.00%
Q2 2018$1,000222
+455.0%
0.00%
Q1 2018$040
-37.5%
0.00%
Q4 2017$064
+611.1%
0.00%
Q3 2017$09
+800.0%
0.00%
Q2 2017$010.00%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Prosight Management, LP 908,488$6,232,0002.88%
Knoll Capital Management, LLC 569,405$3,906,0002.66%
Mesirow Financial Investment Management, Inc. 64,698$443,828,0001.40%
Ghost Tree Capital, LLC 650,000$4,459,0000.99%
Johnson & Johnson Innovation - JJDC, Inc. 594,834$4,081,0000.53%
Perceptive Advisors 6,285,458$43,118,0000.46%
Affinity Asset Advisors, LLC 100,000$686,0000.36%
ACUTA CAPITAL PARTNERS, LLC 192,500$1,321,0000.36%
Avidity Partners Management LP 1,435,000$9,844,0000.32%
APOGEM CAPITAL LLC 55,821$383,0000.26%
View complete list of ALDEYRA THERAPEUTICS INC shareholders